MedTrace Logo

A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma

NCT02482909 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2015-06-26

No results posted yet for this study

Summary

The purpose of this prospective randomized study is to compare the efficacy and safety of radiofrequency ablation and hepatic resection for small hepatocellular carcinomas with very homogeneous underlying conditions.

Conditions

  • Carcinoma, Hepatocellular

Interventions

PROCEDURE

Hepatic resection

Anatomical surgical resection of the liver including the tumor

PROCEDURE

Radiofrequency ablation

Percutaneous ablation using radiofrequency under the imaging guidance

Sponsors & Collaborators

  • National Cancer Center, Korea

    collaborator OTHER_GOV

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kyung-Suk Suh, ME, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2013-05-31
Completion
2013-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02482909 on ClinicalTrials.gov